| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.12e-07 | 37 | 234 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.57e-07 | 38 | 234 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 5.69e-06 | 11 | 234 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 1.56e-05 | 5 | 234 | 3 | GO:0050649 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.68e-05 | 14 | 234 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 3.93e-05 | 79 | 234 | 7 | GO:0004521 | |
| GeneOntologyMolecularFunction | zinc ion binding | TET2 ERVK-6 ZMYM2 ZSWIM2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 TRIP4 RXRA RXRB TRAFD1 GLRA1 ADAMTS20 NR1H2 DMD ERVK-24 NUP153 L3MBTL2 PIAS2 TRIM17 ERVK-8 NEIL3 ZMAT1 ZMYM4 | 5.05e-05 | 891 | 234 | 25 | GO:0008270 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ADAMTS19 ADAM18 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ADAMTS20 PRSS45P ERVK-24 USP1 ADAMTS12 USP6 CAPN7 ERVK-8 KLK8 | 5.12e-05 | 430 | 234 | 16 | GO:0004175 |
| GeneOntologyMolecularFunction | transition metal ion binding | TET2 ERVK-6 KDM3A CYP3A7 CYP3A4 ZMYM2 ZSWIM2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 TRIP4 RXRA RXRB MELTF TRAFD1 GLRA1 ADAMTS20 NR1H2 DMD ERVK-24 NUP153 L3MBTL2 CYP3A43 PIAS2 TRIM17 ERVK-8 NEIL3 ZMAT1 ZMYM4 | 6.20e-05 | 1189 | 234 | 30 | GO:0046914 |
| GeneOntologyMolecularFunction | nuclear receptor binding | KDM3A NRIP1 KDM5D TRIP4 RXRA RXRB NR1H2 TACC1 PIAS2 HSD17B10 | 7.46e-05 | 187 | 234 | 10 | GO:0016922 |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 8.52e-05 | 8 | 234 | 3 | GO:0101021 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 9.41e-05 | 21 | 234 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 1.79e-04 | 10 | 234 | 3 | GO:0005391 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 1.79e-04 | 10 | 234 | 3 | GO:0008554 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.96e-04 | 46 | 234 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.05e-04 | 136 | 234 | 8 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.05e-04 | 136 | 234 | 8 | GO:0004519 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 2.45e-04 | 11 | 234 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 2.45e-04 | 11 | 234 | 3 | GO:0008556 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ADAMTS19 ADAM18 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ADAMTS20 PRSS45P ERVK-24 USP1 SENP8 ADAMTS12 USP6 CAPN7 ERVK-8 KLK8 USP54 USPL1 | 2.70e-04 | 654 | 234 | 19 | GO:0008233 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.00e-04 | 109 | 234 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 3.84e-04 | 53 | 234 | 5 | GO:0030331 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 4.57e-04 | 55 | 234 | 5 | GO:0042974 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 5.26e-04 | 14 | 234 | 3 | GO:0008401 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 8.07e-04 | 36 | 234 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 8.07e-04 | 36 | 234 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 8.08e-04 | 4 | 234 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 8.96e-04 | 37 | 234 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 9.92e-04 | 38 | 234 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.09e-03 | 262 | 234 | 10 | GO:0140097 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.28e-03 | 102 | 234 | 6 | GO:0001540 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 1.34e-03 | 5 | 234 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 1.34e-03 | 5 | 234 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.56e-03 | 20 | 234 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity | 1.59e-03 | 43 | 234 | 4 | GO:0004869 | |
| GeneOntologyMolecularFunction | nuclease activity | ERVK-6 ERVK-7 ERVK-10 SLFN14 XRN1 DNA2 PIWIL2 RNASET2 ERVK-8 | 1.67e-03 | 231 | 234 | 9 | GO:0004518 |
| GeneOntologyMolecularFunction | demethylase activity | 1.73e-03 | 44 | 234 | 4 | GO:0032451 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 1.99e-03 | 6 | 234 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 1.99e-03 | 6 | 234 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated ion channel activity | 1.99e-03 | 6 | 234 | 2 | GO:0016933 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated chloride channel activity | 1.99e-03 | 6 | 234 | 2 | GO:0016934 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 2.37e-03 | 23 | 234 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | retinoic acid-responsive element binding | 2.76e-03 | 7 | 234 | 2 | GO:0044323 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 2.76e-03 | 7 | 234 | 2 | GO:0070643 | |
| GeneOntologyBiologicalProcess | DNA integration | 9.95e-06 | 13 | 230 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | negative regulation of collagen catabolic process | 1.35e-05 | 5 | 230 | 3 | GO:0010711 | |
| GeneOntologyBiologicalProcess | negative regulation of elastin catabolic process | 1.35e-05 | 5 | 230 | 3 | GO:0060311 | |
| GeneOntologyBiologicalProcess | regulation of elastin catabolic process | 2.67e-05 | 6 | 230 | 3 | GO:0060310 | |
| GeneOntologyBiologicalProcess | growth plate cartilage chondrocyte growth | 4.63e-05 | 7 | 230 | 3 | GO:0003430 | |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel remodeling | 4.63e-05 | 7 | 230 | 3 | GO:0060313 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 5.36e-05 | 87 | 230 | 7 | GO:0001974 | |
| GeneOntologyBiologicalProcess | regulation of collagen catabolic process | 1.09e-04 | 9 | 230 | 3 | GO:0010710 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 1.09e-04 | 9 | 230 | 3 | GO:0002933 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | ERVK-6 ABCC4 ERVK-21 MCM3AP NUP153 CPSF6 CR1 EPG5 THOC6 SIDT2 HTT | 1.17e-04 | 249 | 230 | 11 | GO:0015931 |
| GeneOntologyBiologicalProcess | negative regulation of extracellular matrix disassembly | 1.55e-04 | 10 | 230 | 3 | GO:0010716 | |
| GeneOntologyBiologicalProcess | growth plate cartilage chondrocyte development | 1.55e-04 | 10 | 230 | 3 | GO:0003431 | |
| GeneOntologyBiologicalProcess | chondrocyte hypertrophy | 1.55e-04 | 10 | 230 | 3 | GO:0003415 | |
| GeneOntologyBiologicalProcess | elastin catabolic process | 1.55e-04 | 10 | 230 | 3 | GO:0060309 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix disassembly | 1.59e-04 | 25 | 230 | 4 | GO:0010715 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.91e-04 | 48 | 230 | 5 | GO:0000731 | |
| GeneOntologyCellularComponent | microtubule minus-end | 4.40e-05 | 7 | 229 | 3 | GO:0036449 | |
| Domain | DUF4599 | 9.08e-06 | 12 | 223 | 4 | PF15371 | |
| Domain | DUF4599 | 9.08e-06 | 12 | 223 | 4 | IPR027970 | |
| Domain | Cyt_P450_E_grp-II | 1.65e-05 | 5 | 223 | 3 | IPR002402 | |
| Domain | Cyt_P450_E_CYP3A | 3.27e-05 | 6 | 223 | 3 | IPR008072 | |
| Domain | Prot_inh_cystat_CS | 1.34e-04 | 9 | 223 | 3 | IPR018073 | |
| Domain | - | 1.42e-04 | 2 | 223 | 2 | 2.60.40.1450 | |
| Domain | LAG1-DNAbind | 1.42e-04 | 2 | 223 | 2 | PF09271 | |
| Domain | BTD | 1.42e-04 | 2 | 223 | 2 | PF09270 | |
| Domain | BTD | 1.42e-04 | 2 | 223 | 2 | SM01268 | |
| Domain | LAG1_DNAbind | 1.42e-04 | 2 | 223 | 2 | SM01267 | |
| Domain | Beta-trefoil_DNA-bd_dom | 1.42e-04 | 2 | 223 | 2 | IPR015350 | |
| Domain | LAG1_DNA-bd | 1.42e-04 | 2 | 223 | 2 | IPR015351 | |
| Domain | Cystatin | 3.41e-04 | 12 | 223 | 3 | IPR027214 | |
| Domain | CYSTATIN | 3.41e-04 | 12 | 223 | 3 | PS00287 | |
| Domain | ATPase_P-typ_cyto_domN | 7.75e-04 | 35 | 223 | 4 | IPR023299 | |
| Domain | - | 8.38e-04 | 4 | 223 | 2 | 3.90.1460.10 | |
| Domain | Glycine_rcpt_A | 8.38e-04 | 4 | 223 | 2 | IPR008127 | |
| Domain | GTF2I | 8.38e-04 | 4 | 223 | 2 | PS51139 | |
| Domain | GTF2I | 8.38e-04 | 4 | 223 | 2 | PF02946 | |
| Domain | GTF2I | 8.38e-04 | 4 | 223 | 2 | IPR004212 | |
| Domain | ATPase_P-typ_TM_dom | 8.38e-04 | 16 | 223 | 3 | IPR023298 | |
| Domain | - | 8.38e-04 | 16 | 223 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_P_site | 8.63e-04 | 36 | 223 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 8.63e-04 | 36 | 223 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 8.63e-04 | 36 | 223 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 9.59e-04 | 37 | 223 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 9.59e-04 | 37 | 223 | 4 | PF00122 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.01e-03 | 17 | 223 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.01e-03 | 17 | 223 | 3 | PF00689 | |
| Domain | CY | 1.01e-03 | 17 | 223 | 3 | SM00043 | |
| Domain | Pep_M12B_propep | 1.17e-03 | 39 | 223 | 4 | PF01562 | |
| Domain | Peptidase_M12B_N | 1.17e-03 | 39 | 223 | 4 | IPR002870 | |
| Domain | Cation_ATPase_N | 1.20e-03 | 18 | 223 | 3 | PF00690 | |
| Domain | Cystatin_dom | 1.20e-03 | 18 | 223 | 3 | IPR000010 | |
| Domain | Cation_ATPase_N | 1.20e-03 | 18 | 223 | 3 | SM00831 | |
| Domain | Cystatin | 1.20e-03 | 18 | 223 | 3 | PF00031 | |
| Domain | DISINTEGRIN_1 | 1.29e-03 | 40 | 223 | 4 | PS00427 | |
| Domain | Reprolysin | 1.29e-03 | 40 | 223 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 1.29e-03 | 40 | 223 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.29e-03 | 40 | 223 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 1.29e-03 | 40 | 223 | 4 | IPR001590 | |
| Domain | DUF3504 | 1.39e-03 | 5 | 223 | 2 | IPR021893 | |
| Domain | DUF3504 | 1.39e-03 | 5 | 223 | 2 | PF12012 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.41e-03 | 19 | 223 | 3 | IPR004014 | |
| Domain | Disintegrin_dom | 1.42e-03 | 41 | 223 | 4 | IPR001762 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS | 2.51e-08 | 9 | 165 | 5 | M29789 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.12e-06 | 47 | 165 | 7 | M29777 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE | 1.55e-05 | 5 | 165 | 3 | M29791 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE | 1.55e-05 | 5 | 165 | 3 | M29792 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS | 1.55e-05 | 5 | 165 | 3 | M29812 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 3.07e-05 | 6 | 165 | 3 | MM15663 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 3.22e-05 | 32 | 165 | 5 | M39567 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 6.66e-05 | 37 | 165 | 5 | M29790 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 1.26e-04 | 9 | 165 | 3 | M29809 | |
| Pathway | WP_LIVER_X_RECEPTOR_PATHWAY | 1.78e-04 | 10 | 165 | 3 | M39557 | |
| Pubmed | 1.35e-09 | 71 | 236 | 9 | 33541421 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 2.07e-09 | 4 | 236 | 4 | 10469592 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM3A AFTPH ATRX ZMYM2 PFKP SPICE1 PASK BPTF FASN SCML2 TRAFD1 SVIL NUP153 NUMA1 MICALL1 RIF1 UTP18 GTF3C1 CSNK2A2 CCAR2 SRRM2 ZMYM4 | 1.95e-08 | 774 | 236 | 22 | 15302935 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TET2 NRIP1 ABCC4 ZNF462 BPTF MELTF SVIL N4BP2L2 TACC1 BRD1 PPP4R1 PIAS2 USP6 RIF1 SIDT2 RBPJ MPHOSPH9 MBD5 | 3.40e-08 | 536 | 236 | 18 | 15840001 |
| Pubmed | TET2 NRIP1 ABCC4 ZNF462 BPTF MELTF SVIL N4BP2L2 TACC1 BRD1 PPP4R1 PIAS2 USP6 RIF1 SIDT2 RBPJ MPHOSPH9 MBD5 | 3.60e-08 | 538 | 236 | 18 | 10512203 | |
| Pubmed | ATRX CENPF GARS1 HMGB3 PFKP MDH2 BPTF FASN RRP36 XRN1 ASPM GTF2IRD2 NAV2 DMD DTHD1 USP1 ABCB5 NUMA1 TEX14 THOC6 ADAMTS12 GTF2IRD2B UTP18 GTF3C1 TNN CCAR2 PADI6 ATP1A1 USPL1 ZNF292 | 5.63e-08 | 1442 | 236 | 30 | 35575683 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KDM3A ATRX ZMYM2 HMGB3 ZNF462 FSIP2 BPTF SCML2 BRD1 L3MBTL2 NUMA1 PIAS2 RIF1 GTF3C1 CSNK2A2 RBPJ ZMYM4 ZNF292 | 2.21e-07 | 608 | 236 | 18 | 36089195 |
| Pubmed | Translational deregulation in PDK-1-/- embryonic stem cells. | 2.54e-07 | 9 | 236 | 4 | 16166629 | |
| Pubmed | 3.09e-07 | 3 | 236 | 3 | 1471486 | ||
| Pubmed | 3.09e-07 | 3 | 236 | 3 | 1898352 | ||
| Pubmed | 3.09e-07 | 3 | 236 | 3 | 1778989 | ||
| Pubmed | AFTPH CENPF ZMYM2 PFKP FASN TRAFD1 MYPN NAV2 NUP153 TROAP NUMA1 RIF1 UTP18 GTF3C1 DCP1B SRRM2 | 4.13e-07 | 503 | 236 | 16 | 16964243 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ATRX ZMYM2 PFKP BPTF FASN TRMT1L PDCD6IP NUMA1 PIAS2 RIF1 GTF3C1 CCAR2 SRRM2 | 5.20e-07 | 332 | 236 | 13 | 32786267 |
| Pubmed | TET2 ATRX ZMYM2 HMGB3 PFKP RXRA ZNF462 BPTF SVIL XRN1 TRMT1L L3MBTL2 NUMA1 ZNF521 PIAS2 KIAA1671 RIF1 CCDC59 GTF3C1 DCP1B CSNK2A2 RBPJ CSTF1 CCAR2 USP54 ATP1A1 SRRM2 ZMYM4 | 5.39e-07 | 1429 | 236 | 28 | 35140242 | |
| Pubmed | 9.80e-07 | 12 | 236 | 4 | 14557543 | ||
| Pubmed | 1.23e-06 | 4 | 236 | 3 | 12549917 | ||
| Pubmed | 1.23e-06 | 4 | 236 | 3 | 13679380 | ||
| Pubmed | 1.23e-06 | 4 | 236 | 3 | 10713450 | ||
| Pubmed | Sequence diversity and haplotype structure at the human CYP3A cluster. | 1.41e-06 | 13 | 236 | 4 | 16314882 | |
| Pubmed | 1.43e-06 | 29 | 236 | 5 | 15071553 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 NRIP1 CENPF SPATA31A6 TRAFD1 NAV2 CPSF6 NUMA1 GTF3C1 XIRP2 PDIK1L CAPN7 GAN ATP1A1 ZNF292 | 1.83e-06 | 497 | 236 | 15 | 36774506 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 AFTPH PFKP SPICE1 FSIP2 SVIL XRN1 NADK NAV2 BRD1 WNK3 PDCD6IP GRK7 MICALL1 KIAA1671 DCP1B GAN MPHOSPH9 USP54 SRRM2 | 2.06e-06 | 861 | 236 | 20 | 36931259 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | AFTPH TRIP4 SPICE1 PASK TRAFD1 MCM3AP MYPN XRN1 DMD FERMT2 PIH1D1 PPP4R1 L3MBTL2 CPSF6 AP3B1 UTP18 ARRB2 DCP1B CSNK2A2 RBPJ CCAR2 MPHOSPH9 | 2.77e-06 | 1038 | 236 | 22 | 26673895 |
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 3.05e-06 | 5 | 236 | 3 | 11266076 | |
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 21443774 | ||
| Pubmed | Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis. | 3.05e-06 | 5 | 236 | 3 | 27079462 | |
| Pubmed | Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation. | 3.05e-06 | 5 | 236 | 3 | 20489058 | |
| Pubmed | Neuroprotection mediated by cystatin C-loaded extracellular vesicles. | 3.05e-06 | 5 | 236 | 3 | 31367000 | |
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 33754041 | ||
| Pubmed | Carminerin contributes to chondrocyte calcification during endochondral ossification. | 3.05e-06 | 5 | 236 | 3 | 16680148 | |
| Pubmed | Evolution of C, D and S-type cystatins in mammals: an extensive gene duplication in primates. | 3.05e-06 | 5 | 236 | 3 | 25329717 | |
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 20472891 | ||
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 23671283 | ||
| Pubmed | Cystatin C stimulates the differentiation of mouse osteoblastic cells and bone formation. | 3.05e-06 | 5 | 236 | 3 | 17592728 | |
| Pubmed | Obesity-Induced Increase in Cystatin C Alleviates Tissue Inflammation. | 3.05e-06 | 5 | 236 | 3 | 32616516 | |
| Pubmed | Transforming growth factor beta regulates cystatin C in serum-free mouse embryo (SFME) cells. | 3.05e-06 | 5 | 236 | 3 | 2241983 | |
| Pubmed | Strong conservation of the expression of cystatin C gene in choroid plexus. | 3.05e-06 | 5 | 236 | 3 | 1636787 | |
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 15450354 | ||
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 10748866 | ||
| Pubmed | Cystatin C deficiency promotes epidermal dysplasia in K14-HPV16 transgenic mice. | 3.05e-06 | 5 | 236 | 3 | 21085595 | |
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 16595632 | ||
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 12044447 | ||
| Pubmed | Cystatin C triggers neuronal degeneration in a model of multiple system atrophy. | 3.05e-06 | 5 | 236 | 3 | 24405769 | |
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 19773092 | ||
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 24570004 | ||
| Pubmed | Dissecting the Genetic Architecture of Cystatin C in Diversity Outbred Mice. | 3.05e-06 | 5 | 236 | 3 | 32467129 | |
| Pubmed | Cystatin C Plays a Sex-Dependent Detrimental Role in Experimental Autoimmune Encephalomyelitis. | 3.05e-06 | 5 | 236 | 3 | 33027652 | |
| Pubmed | Cystatin C Deficiency Increases LPS-Induced Sepsis and NLRP3 Inflammasome Activation in Mice. | 3.05e-06 | 5 | 236 | 3 | 34440840 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 3.05e-06 | 5 | 236 | 3 | 12629516 | |
| Pubmed | Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution. | 3.05e-06 | 5 | 236 | 3 | 8761177 | |
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 14742906 | ||
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 15823274 | ||
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 34914637 | ||
| Pubmed | FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. | 3.05e-06 | 5 | 236 | 3 | 11144350 | |
| Pubmed | Loss of cystatin C regulates permeability and inflammatory pathways in retina. | 3.05e-06 | 5 | 236 | 3 | 36822364 | |
| Pubmed | Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse. | 3.05e-06 | 5 | 236 | 3 | 16242633 | |
| Pubmed | pH-dependent and dynamic interactions of cystatin C with heparan sulfate. | 3.05e-06 | 5 | 236 | 3 | 33580179 | |
| Pubmed | CST3 alleviates retinal vascular leakage by regulating the Rap1 signaling pathway. | 3.05e-06 | 5 | 236 | 3 | 39147193 | |
| Pubmed | 3.05e-06 | 5 | 236 | 3 | 24500719 | ||
| Pubmed | Control and expression of cystatin C by mouse decidual cultures. | 3.05e-06 | 5 | 236 | 3 | 11803549 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 3.76e-06 | 94 | 236 | 7 | 21542922 | |
| Pubmed | AFTPH CENPF BPTF SCML2 SERPINB12 ASPM TACC1 TRMT1L PIH1D1 PDCD6IP RIF1 HSD17B10 SRRM2 CDK7 | 4.95e-06 | 472 | 236 | 14 | 38943005 | |
| Pubmed | 5.87e-06 | 18 | 236 | 4 | 18664271 | ||
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 26592151 | ||
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 14607896 | ||
| Pubmed | Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. | 6.08e-06 | 6 | 236 | 3 | 16365041 | |
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 11879580 | ||
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 15930522 | ||
| Pubmed | Megalin-mediated endocytosis of cystatin C in proximal tubule cells. | 6.08e-06 | 6 | 236 | 3 | 17462596 | |
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 15653570 | ||
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 20889561 | ||
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 16051881 | ||
| Pubmed | Epithelial cell-derived cytokines CST3 and GDF15 as potential therapeutics for pulmonary fibrosis. | 6.08e-06 | 6 | 236 | 3 | 29724997 | |
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 25356866 | ||
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 18026102 | ||
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 20352108 | ||
| Pubmed | Macrophage responses to interferon-gamma are dependent on cystatin C levels. | 6.08e-06 | 6 | 236 | 3 | 19446036 | |
| Pubmed | 6.08e-06 | 6 | 236 | 3 | 11472890 | ||
| Pubmed | TET2 NRIP1 CENPF ZMYM2 ZNF462 FASN XRN1 L3MBTL2 PIAS2 KIAA1671 ARRB2 GTF3C1 ZMYM4 | 6.54e-06 | 418 | 236 | 13 | 34709266 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CENPF PFKP MDH2 BPTF FASN RRP36 SERPINB12 SVIL NUP153 CACNA2D1 NIBAN1 PDCD6IP CPSF6 NUMA1 KIAA1671 RIF1 GTF3C1 CCAR2 HSD17B10 ATP1A1 SRRM2 | 7.77e-06 | 1024 | 236 | 21 | 24711643 |
| Pubmed | 8.47e-06 | 41 | 236 | 5 | 25810521 | ||
| Pubmed | 1.06e-05 | 7 | 236 | 3 | 7835704 | ||
| Pubmed | Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein. | 1.06e-05 | 7 | 236 | 3 | 23024364 | |
| Pubmed | 1.06e-05 | 7 | 236 | 3 | 27693425 | ||
| Pubmed | 1.06e-05 | 7 | 236 | 3 | 10229662 | ||
| Pubmed | 1.06e-05 | 7 | 236 | 3 | 18681831 | ||
| Pubmed | 1.06e-05 | 7 | 236 | 3 | 31513306 | ||
| Pubmed | 1.06e-05 | 7 | 236 | 3 | 18957217 | ||
| Pubmed | The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. | 1.06e-05 | 7 | 236 | 3 | 11137287 | |
| Pubmed | 1.06e-05 | 7 | 236 | 3 | 21300820 | ||
| Pubmed | Isolation of cystatin C via functional cloning of astrocyte differentiation factors. | 1.06e-05 | 7 | 236 | 3 | 15509901 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.11e-05 | 256 | 236 | 10 | 33397691 | |
| Pubmed | CENPF PFKP BPTF FASN MCM3AP XRN1 NUP153 PDCD6IP NUMA1 RIF1 UTP18 GTF3C1 CSNK2A2 CCAR2 ATP1A1 SRRM2 | 1.16e-05 | 653 | 236 | 16 | 22586326 | |
| Pubmed | Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2. | 1.35e-05 | 45 | 236 | 5 | 27337956 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CENPF GARS1 ZMYM2 SPICE1 FANCB FASN WFDC2 SERPINB12 SVIL MYPN ASPM CCDC15 NUP153 CACNA2D1 PDCD6IP L3MBTL2 TROAP NUMA1 ARRB2 GTF3C1 CCAR2 ZMYM4 | 1.48e-05 | 1155 | 236 | 22 | 20360068 |
| Pubmed | 1.68e-05 | 8 | 236 | 3 | 20093401 | ||
| Pubmed | 1.68e-05 | 8 | 236 | 3 | 9310336 | ||
| Pubmed | Genomic cloning, physical mapping, and expression of human type 2 cystatin genes. | 1.68e-05 | 8 | 236 | 3 | 7690606 | |
| Pubmed | 1.68e-05 | 8 | 236 | 3 | 11856874 | ||
| Pubmed | 1.68e-05 | 8 | 236 | 3 | 29431742 | ||
| Interaction | TRIM52 interactions | KIAA0586 SPICE1 ASPM ZBTB5 DNA2 L3MBTL2 TROAP GTF3C1 CCAR2 USP54 ZNF445 | 3.44e-07 | 133 | 228 | 11 | int:TRIM52 |
| Interaction | ZDHHC15 interactions | 1.61e-06 | 125 | 228 | 10 | int:ZDHHC15 | |
| Interaction | SUMO2 interactions | ATRX ZMYM2 PFKP BPTF FASN TRMT1L NUP153 PDCD6IP NUMA1 PIAS2 RIF1 ARRB2 GTF3C1 CCAR2 HSD17B10 USPL1 SRRM2 ZMYM4 HTT CDK7 | 1.39e-05 | 591 | 228 | 20 | int:SUMO2 |
| Interaction | H3C3 interactions | KDM3A ATRX ZMYM2 HMGB3 ZNF462 FSIP2 BPTF SCML2 BRD1 L3MBTL2 NUMA1 PIAS2 RIF1 GTF3C1 CSNK2A2 RBPJ ZMYM4 ZNF292 | 1.46e-05 | 495 | 228 | 18 | int:H3C3 |
| Cytoband | 18p11.22 | 8.65e-05 | 17 | 236 | 3 | 18p11.22 | |
| Cytoband | 9q21.32 | 1.22e-04 | 19 | 236 | 3 | 9q21.32 | |
| GeneFamily | Cytochrome P450 family 3 | 2.53e-05 | 8 | 141 | 3 | 1002 | |
| GeneFamily | Cystatins, type 2 | 2.41e-04 | 16 | 141 | 3 | 965 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 4.11e-04 | 19 | 141 | 3 | 50 | |
| GeneFamily | Glycine receptors | 5.95e-04 | 5 | 141 | 2 | 868 | |
| GeneFamily | Zinc fingers MYM-type | 8.87e-04 | 6 | 141 | 2 | 86 | |
| GeneFamily | Ubiquitin specific peptidases | 9.51e-04 | 56 | 141 | 4 | 366 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 1.24e-03 | 7 | 141 | 2 | 1208 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 2.10e-03 | 9 | 141 | 2 | 1263 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | ZMYM2 HMGB3 RXRB PCDH11X TACC1 TRMT1L BRD1 USP1 MLANA RBL1 NUMA1 CR1 ATP10D CCDC59 CSNK2A2 RNASET2 RBPJ | 5.86e-08 | 389 | 227 | 17 | M6520 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 AFTPH ATRX CENPF KIAA0586 ZMYM2 NCKAP5 PTPRZ1 ASPM CCDC15 ADAMTS20 N4BP2L2 DMD MAP3K19 CACNA2D1 SGTB PDCD6IP NUMA1 FHOD3 SENP8 AP3B1 IFNAR1 RIF1 DCP1B PDIK1L CAPN7 NEIL3 MPHOSPH9 ZNF292 | 1.81e-08 | 831 | 225 | 29 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | BDP1 ATRX CENPF KIAA0586 ZMYM2 GLRA1 ASPM CCDC15 N4BP2L2 MAP3K19 CACNA2D1 SGTB AP3B1 RIF1 MPHOSPH9 ZNF292 | 2.32e-07 | 311 | 225 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | BDP1 AFTPH ATRX CENPF KIAA0586 ZMYM2 NCKAP5 RXRA PTPRZ1 GLRA1 PCDH11X ASPM NAV2 CCDC15 N4BP2L2 DMD MAP3K19 CACNA2D1 SGTB FHOD3 SENP8 AP3B1 RIF1 ARRB2 DCP1B MPHOSPH9 ZNF292 | 6.65e-06 | 989 | 225 | 27 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | IL12RB2 ATRX CENPF KIAA0586 ZMYM2 NCKAP5 ZNF462 FASN AUNIP PTPRZ1 ATP2C2 ASPM CCDC15 DMD BRD1 DNA2 USP1 WNK3 ZNF823 SGTB CPSF6 RBL1 FHOD3 SENP8 RIF1 ARRB2 PDIK1L ZNF292 | 8.19e-06 | 1060 | 225 | 28 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NRIP1 ATRX KDM5D ZNF462 SCML2 PCDH11X ASPM NAV2 ANKRD12 COL1A2 COL6A2 STARD4 SENP8 IFNAR1 LIFR RIF1 PIEZO2 PDIK1L GAN NEIL3 HTT CDK7 ZNF445 | 1.52e-05 | 801 | 225 | 23 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | NRIP1 ATRX KIAA0586 KDM5D ZNF462 SCML2 PLA1A ASPM NAV2 TACC1 TBX20 NUP153 SH3TC2 STARD4 PIWIL2 TEX14 SENP8 IFNAR1 RIF1 GAN HTT CDK7 ZNF445 | 1.68e-05 | 806 | 225 | 23 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BDP1 IL12RB2 ATRX CENPF KIAA0586 ZMYM2 HMGB3 TRIP4 ZNF462 BPTF FASN AUNIP PTPRZ1 ASPM DMD BRD1 DNA2 USP1 WNK3 ZNF823 PPP4R1 SGTB L3MBTL2 CPSF6 RBL1 FHOD3 SENP8 RIF1 MBD5 ZNF292 | 2.67e-05 | 1257 | 225 | 30 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 AFTPH ATRX CENPF KIAA0586 ZMYM2 GLRA1 ADAMTS20 N4BP2L2 USP1 SGTB PDCD6IP RBL1 NUMA1 AP3B1 IFNAR1 CAPN7 NEIL3 MPHOSPH9 MBD5 ZMYM4 | 9.08e-05 | 780 | 225 | 21 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | CYB5D2 NRIP1 AFTPH ATRX KIAA0586 FOCAD SCML2 ASPM NAV2 ANKRD12 COL6A2 PIWIL2 TEX14 SENP8 IFNAR1 RIF1 PDIK1L GAN ZMAT1 HTT ZNF445 | 1.18e-04 | 795 | 225 | 21 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | NRIP1 ATRX SCML2 PCDH11X ASPM NAV2 TBX20 NUP153 PIWIL2 TEX14 SENP8 IFNAR1 RIF1 GAN | 1.27e-04 | 409 | 225 | 14 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | ATRX KDM5D INPP4B PCDH11X ASPM ZNF823 STARD4 CPSF6 PIEZO2 ZNF292 ZNF445 | 1.34e-04 | 266 | 225 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | NRIP1 ATRX KIAA0586 PCDH11X ASPM NAV2 STARD4 GAN NEIL3 CDK7 ZNF445 | 1.91e-04 | 277 | 225 | 11 | gudmap_developingGonad_e12.5_ovary_k3_1000 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CENPF INPP4B PRR16 FANCB ASPM CCDC15 COL1A2 TROAP ADAMTS12 NEIL3 CDH11 | 1.51e-09 | 171 | 229 | 11 | b0373ed8283ee1792b6a490bff93906546978593 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CENPF INPP4B PRR16 FANCB ASPM CCDC15 COL1A2 TROAP ADAMTS12 NEIL3 CDH11 | 1.51e-09 | 171 | 229 | 11 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 MELTF PCDH11X ADAMTS20 DMD UNC79 PIEZO2 XIRP2 UNC13C MYO16 | 4.23e-08 | 184 | 229 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 MELTF PCDH11X ADAMTS20 DMD UNC79 PIEZO2 XIRP2 UNC13C MYO16 | 4.23e-08 | 184 | 229 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 MELTF PCDH11X ADAMTS20 DMD UNC79 PIEZO2 XIRP2 UNC13C MYO16 | 4.23e-08 | 184 | 229 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA9 INPP4B PRR16 NAV2 DMD COL1A2 COL6A2 ADAMTS12 EEPD1 CDH11 | 6.02e-08 | 191 | 229 | 10 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA9 INPP4B PRR16 NAV2 DMD COL1A2 COL6A2 ADAMTS12 EEPD1 CDH11 | 6.02e-08 | 191 | 229 | 10 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA9 INPP4B PRR16 NAV2 DMD COL1A2 COL6A2 ATP10D ADAMTS12 CDH11 | 6.32e-08 | 192 | 229 | 10 | bc84b9ce01b4d826a682842ab8a395dac9b91183 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA9 INPP4B PRR16 NAV2 DMD COL1A2 COL6A2 ATP10D ADAMTS12 CDH11 | 6.32e-08 | 192 | 229 | 10 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | NCKAP5 INPP4B SVIL MYPN DMD CACNA2D1 NIBAN1 FHOD3 DCP1B XIRP2 | 6.64e-08 | 193 | 229 | 10 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ITGA9 PRR16 PCDH11X DMD PZP COL1A2 COL6A2 CACNA2D1 ADAMTS12 CDH11 | 8.84e-08 | 199 | 229 | 10 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c |
| ToppCell | Transverse-(2)_B_cell-(24)_B_cell_cycling|Transverse / shred on region, Cell_type, and subtype | 9.26e-08 | 200 | 229 | 10 | e3f9736227151f23f0e331eec0a7a15ce464b517 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|Transverse / Region, Cell class and subclass | 9.26e-08 | 200 | 229 | 10 | 0e270f8019d9f22068ca426d661937262a5cd331 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-07 | 163 | 229 | 9 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-07 | 163 | 229 | 9 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-07 | 178 | 229 | 9 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.92e-07 | 179 | 229 | 9 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.31e-07 | 181 | 229 | 9 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 4.51e-07 | 182 | 229 | 9 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-07 | 184 | 229 | 9 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.18e-07 | 185 | 229 | 9 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-07 | 187 | 229 | 9 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-07 | 187 | 229 | 9 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.19e-07 | 189 | 229 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 6.47e-07 | 190 | 229 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | INPP4B PRR16 COL1A2 COL6A2 CACNA2D1 NIBAN1 ADAMTS12 PIEZO2 CDH11 | 6.76e-07 | 191 | 229 | 9 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.07e-07 | 192 | 229 | 9 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CNTNAP3B CNTNAP3 NDST4 MYPN PCDH11X NAV2 ADAMTS20 CRB1 RNASET2 | 7.38e-07 | 193 | 229 | 9 | 8b77625bf3c87d39767fb391d1beaca4ab02342b |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.38e-07 | 193 | 229 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.70e-07 | 194 | 229 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.70e-07 | 194 | 229 | 9 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | PRR16 COL1A2 COL6A2 CACNA2D1 ADAMTS12 LIFR PIEZO2 UNC13C CDH11 | 8.04e-07 | 195 | 229 | 9 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | PRR16 COL1A2 COL6A2 CACNA2D1 ADAMTS12 LIFR PIEZO2 UNC13C CDH11 | 8.39e-07 | 196 | 229 | 9 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.39e-07 | 196 | 229 | 9 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.39e-07 | 196 | 229 | 9 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | PRR16 COL1A2 COL6A2 CACNA2D1 ADAMTS12 LIFR PIEZO2 UNC13C CDH11 | 8.39e-07 | 196 | 229 | 9 | 22538376a95fe3afe8639a216a5497087aa94110 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.75e-07 | 197 | 229 | 9 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.75e-07 | 197 | 229 | 9 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.75e-07 | 197 | 229 | 9 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | INPP4B PRR16 NAV2 COL1A2 COL6A2 CACNA2D1 ADAMTS12 PIEZO2 CDH11 | 9.13e-07 | 198 | 229 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | PRR16 COL1A2 COL6A2 CACNA2D1 ZNF521 ADAMTS12 LIFR PIEZO2 CDH11 | 9.13e-07 | 198 | 229 | 9 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 9.13e-07 | 198 | 229 | 9 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.52e-07 | 199 | 229 | 9 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | PRR16 COL1A2 COL6A2 CACNA2D1 ADAMTS12 LIFR PIEZO2 UNC13C CDH11 | 9.52e-07 | 199 | 229 | 9 | a09292de4c4447b8eee55d401808e43b817321cc |
| ToppCell | Transverse-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 9.52e-07 | 199 | 229 | 9 | 170ae68963d31f3b821b6f0e8f0c039bea0bc981 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.93e-07 | 200 | 229 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 9.93e-07 | 200 | 229 | 9 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 9.93e-07 | 200 | 229 | 9 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | (24)_B_cell_cycling|World / shred on Cell_type and subtype | 1.08e-06 | 202 | 229 | 9 | a7c9b6b173701348ba35fbb975e0bdd3c1f1d5fe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 155 | 229 | 8 | 82e602f31981c6b48abff2a04b2ab5d26d4462a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 155 | 229 | 8 | 979c1d53b435a82c57d16707eed8ba7346326866 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-06 | 167 | 229 | 8 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 2.88e-06 | 170 | 229 | 8 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.88e-06 | 170 | 229 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 3.00e-06 | 171 | 229 | 8 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.57e-06 | 175 | 229 | 8 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.57e-06 | 175 | 229 | 8 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.67e-06 | 124 | 229 | 7 | d88bce8a4f023d5b617b2e8e372a94bd1248d20d | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 3.72e-06 | 176 | 229 | 8 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.72e-06 | 176 | 229 | 8 | 4bba41ebf9dd187c8705a6997ed039878de62b4e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.04e-06 | 178 | 229 | 8 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | control-Lymphoid-NKT-proliferating|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.39e-06 | 180 | 229 | 8 | 535535a67b3f3320bad2f98b1bc98a7b0ee77840 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.39e-06 | 180 | 229 | 8 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 4.76e-06 | 182 | 229 | 8 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.96e-06 | 183 | 229 | 8 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.96e-06 | 183 | 229 | 8 | 5ac38a2ce93c53f23a89faf287b81ea138560623 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-06 | 186 | 229 | 8 | 4fe8e0bf74c7dbf73634cafdacad89020d2634d0 | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 5.59e-06 | 186 | 229 | 8 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.59e-06 | 186 | 229 | 8 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.81e-06 | 187 | 229 | 8 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-06 | 189 | 229 | 8 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-06 | 189 | 229 | 8 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 6.53e-06 | 190 | 229 | 8 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.53e-06 | 190 | 229 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 6.53e-06 | 190 | 229 | 8 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.53e-06 | 190 | 229 | 8 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 191 | 229 | 8 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 191 | 229 | 8 | 9d7d680da3979e256191b534ebd14c5383e0cf93 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-06 | 191 | 229 | 8 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-06 | 191 | 229 | 8 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 191 | 229 | 8 | 543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-06 | 192 | 229 | 8 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.05e-06 | 192 | 229 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-06 | 192 | 229 | 8 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.05e-06 | 192 | 229 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.05e-06 | 192 | 229 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-06 | 192 | 229 | 8 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-06 | 193 | 229 | 8 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-06 | 193 | 229 | 8 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 193 | 229 | 8 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.33e-06 | 193 | 229 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.33e-06 | 193 | 229 | 8 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.33e-06 | 193 | 229 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-06 | 194 | 229 | 8 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-06 | 194 | 229 | 8 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-06 | 194 | 229 | 8 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-06 | 194 | 229 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 3'_v3-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 7.61e-06 | 194 | 229 | 8 | 7b7f1714c4a9d9519c4d0e460cb87f2eb82392dd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-06 | 194 | 229 | 8 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 7.61e-06 | 194 | 229 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.64e-05 | 195 | 219 | 9 | DOID:1574 (implicated_via_orthology) | |
| Disease | cystatin-SN measurement | 3.28e-05 | 9 | 219 | 3 | EFO_0008106 | |
| Disease | epiandrosterone sulfate measurement | 3.30e-05 | 25 | 219 | 4 | EFO_0021120 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 6.37e-05 | 11 | 219 | 3 | EFO_0801531 | |
| Disease | Intellectual Disability | ZMYM2 HMGB3 ZNF462 BPTF FASN TAT CACNA1B RNASET2 SLC4A10 ATP1A1 HTT ZNF292 | 1.41e-04 | 447 | 219 | 12 | C3714756 |
| Disease | cystatin-D measurement | 2.54e-04 | 17 | 219 | 3 | EFO_0008103 | |
| Disease | tacrolimus measurement | 3.26e-04 | 4 | 219 | 2 | EFO_0008458 | |
| Disease | estrone conjugate measurement | 3.26e-04 | 4 | 219 | 2 | EFO_0007971 | |
| Disease | metabolonic lactone sulfate measurement | 3.58e-04 | 19 | 219 | 3 | EFO_0800659 | |
| Disease | Malignant neoplasm of breast | ADAMTS19 KDM3A NRIP1 ABCA4 CENPF CYP3A4 ITGA9 RXRB INPP4B FASN MTMR3 AKT2 DMD EPG5 MICALL1 PPP1R3A RIF1 CST4 USP54 | 4.45e-04 | 1074 | 219 | 19 | C0006142 |
| Disease | tauro-beta-muricholate measurement | 5.40e-04 | 5 | 219 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 5.40e-04 | 5 | 219 | 2 | EFO_0800569 | |
| Disease | severe acute respiratory syndrome, COVID-19 | RASSF5 PCDH11X DMD SEMA4B CACNA2D1 SGTB CPSF6 MICALL1 ADAMTS12 SLC4A10 UNC13C | 5.52e-04 | 447 | 219 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | non-alcoholic fatty liver disease, cirrhosis of liver | 6.50e-04 | 53 | 219 | 4 | EFO_0001422, EFO_0003095 | |
| Disease | aortic valve disease (implicated_via_orthology) | 8.07e-04 | 6 | 219 | 2 | DOID:62 (implicated_via_orthology) | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 8.07e-04 | 6 | 219 | 2 | EFO_0021119 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 8.07e-04 | 6 | 219 | 2 | EFO_0800294 | |
| Disease | Hypertrophic Cardiomyopathy | 8.57e-04 | 57 | 219 | 4 | C0007194 | |
| Disease | Depressive Symptoms | 9.24e-04 | 26 | 219 | 3 | C0086132 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 1.12e-03 | 7 | 219 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | X-24574 measurement | 1.12e-03 | 7 | 219 | 2 | EFO_0800897 | |
| Disease | hypoglycemia (is_implicated_in) | 1.49e-03 | 8 | 219 | 2 | DOID:9993 (is_implicated_in) | |
| Disease | cystatin-SA measurement | 1.49e-03 | 8 | 219 | 2 | EFO_0008105 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.49e-03 | 8 | 219 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Ventricular Dysfunction | 1.49e-03 | 8 | 219 | 2 | C0242973 | |
| Disease | late-onset Alzheimers disease | 1.60e-03 | 292 | 219 | 8 | EFO_1001870 | |
| Disease | dehydroepiandrosterone sulphate measurement | 1.66e-03 | 68 | 219 | 4 | EFO_0007001 | |
| Disease | androsterone sulfate measurement | 1.87e-03 | 33 | 219 | 3 | EFO_0021117 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.91e-03 | 9 | 219 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 1.91e-03 | 9 | 219 | 2 | EFO_0800278 | |
| Disease | lean body mass | 2.21e-03 | 379 | 219 | 9 | EFO_0004995 | |
| Disease | electroencephalogram measurement | 2.26e-03 | 74 | 219 | 4 | EFO_0004357 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 2.37e-03 | 10 | 219 | 2 | EFO_0022090 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 2.37e-03 | 10 | 219 | 2 | EFO_0800289 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.38e-03 | 75 | 219 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Schizophrenia | NRIP1 CYP3A4 RTN4R PTPRZ1 BRD1 WNK3 CACNA1B CCDC137 TSNARE1 GRM2 ADAMTS12 LIFR PDIK1L ERVK-8 MYO16 | 2.61e-03 | 883 | 219 | 15 | C0036341 |
| Disease | X-12063 measurement | 2.74e-03 | 186 | 219 | 6 | EFO_0021283 | |
| Disease | endometrial neoplasm | 2.89e-03 | 11 | 219 | 2 | EFO_0004230 | |
| Disease | chemotherapy-induced alopecia, response to antimicrotubule agent | 2.89e-03 | 11 | 219 | 2 | EFO_0005260, EFO_0005400 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 2.89e-03 | 11 | 219 | 2 | EFO_0800295 | |
| Disease | nervous system disease (implicated_via_orthology) | 3.45e-03 | 12 | 219 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | methionine sulfone measurement | 3.45e-03 | 12 | 219 | 2 | EFO_0800072 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 3.45e-03 | 12 | 219 | 2 | EFO_0800291 | |
| Disease | Charcot-Marie-Tooth disease | 3.74e-03 | 42 | 219 | 3 | cv:C0007959 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 4.05e-03 | 13 | 219 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 4.05e-03 | 13 | 219 | 2 | EFO_0800284 | |
| Disease | Pneumoconiosis | 4.71e-03 | 14 | 219 | 2 | C0032273 | |
| Disease | Bagassosis | 4.71e-03 | 14 | 219 | 2 | C0004681 | |
| Disease | X-21470 measurement | 4.71e-03 | 14 | 219 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 4.71e-03 | 14 | 219 | 2 | EFO_0800283 | |
| Disease | waist-hip ratio | TET2 ITGA9 BPTF ZSCAN30 XRN1 ADAMTS20 COL6A2 PDCD6IP HECTD4 AP3B1 PPP1R3A UTP18 DCP1B CSNK2A2 RBPJ ATP1B3 ZMYM4 HTT | 4.76e-03 | 1226 | 219 | 18 | EFO_0004343 |
| Disease | selective IgA deficiency disease | 4.84e-03 | 46 | 219 | 3 | EFO_1001929 | |
| Disease | amino acid measurement | ADAMTS19 ABCC4 RTN4R CNTNAP3 PASK CACNA2D1 GTF2A1L CSNK2A2 GAN UNC13C MYO16 HTT | 4.97e-03 | 678 | 219 | 12 | EFO_0005134 |
| Disease | anemia (implicated_via_orthology) | 5.40e-03 | 15 | 219 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 5.40e-03 | 15 | 219 | 2 | EFO_0800301 | |
| Disease | decreased susceptibility to hepatitis C infection | 6.14e-03 | 16 | 219 | 2 | EFO_0010101 | |
| Disease | Inherited oocyte maturation defect | 6.14e-03 | 16 | 219 | 2 | cv:CN238505 | |
| Disease | X-21410 measurement | 6.14e-03 | 16 | 219 | 2 | EFO_0800813 | |
| Disease | lower body strength measurement | 6.14e-03 | 16 | 219 | 2 | EFO_0007999 | |
| Disease | fourth ventricle volume measurement | 6.14e-03 | 16 | 219 | 2 | EFO_0010303 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 6.14e-03 | 16 | 219 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 6.14e-03 | 16 | 219 | 2 | EFO_0800305 | |
| Disease | body weight | TET2 PRR16 BPTF FASN GLRA1 MTMR3 NADK DMD DNA2 UNC79 CACNA1B GTF2A1L HECTD4 ZNF521 AP3B1 CRB1 PPP1R3A UTP18 | 6.32e-03 | 1261 | 219 | 18 | EFO_0004338 |
| Disease | Colorectal Carcinoma | TET2 CYB5D2 ABCC4 ABCA4 MCM3AP PCDH11X DMD PZP ABCB5 LIFR ZMYM4 ZNF292 | 6.50e-03 | 702 | 219 | 12 | C0009402 |
| Disease | daytime rest measurement | 6.72e-03 | 295 | 219 | 7 | EFO_0007828 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 6.93e-03 | 17 | 219 | 2 | C1839839 | |
| Disease | uridine diphosphate galactose measurement, uridine diphosphate glucose measurement | 6.93e-03 | 17 | 219 | 2 | EFO_0010543, EFO_0010544 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 6.93e-03 | 17 | 219 | 2 | DOID:0060307 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKTCSKPSENEVPQQ | 111 | O75410 | |
| DQTLPPLNNFSVAEC | 46 | P31751 | |
| ALCQQKAAEAAPPTQ | 441 | Q8N163 | |
| SDKTANIVENPCPEI | 801 | Q68DN1 | |
| VNCKPKNQDEQEIPF | 51 | Q6PK04 | |
| SLQPAQCKQQLQDPE | 741 | Q9HCE0 | |
| SECNSNKENSERPPV | 71 | O95696 | |
| VEEQYLNKLTSCPQP | 1786 | A6H8Y1 | |
| CEVTVQSPTPFNDNQ | 861 | Q9BZ76 | |
| PREKAGQTPQDSNVC | 1306 | P78363 | |
| ESPEPDCQKQFQAAV | 6 | Q8NC06 | |
| TCTSDQFQESLPPVQ | 791 | Q6ULP2 | |
| VPQEPVLFNCSIAEN | 1096 | Q2M3G0 | |
| ERSENCGFKNSQPLP | 526 | Q9Y3Q7 | |
| SEPCLQNEVKSVQPG | 501 | Q14416 | |
| CPLTFENVKVPEANI | 261 | P45954 | |
| KDIPFNLTNNIPGCE | 281 | Q8IYA2 | |
| VEKENIFQRTPCPAF | 21 | A6NFU0 | |
| PSVRSCFQFANNKPE | 3261 | P11532 | |
| TRDFICPNSNIPDQE | 1431 | Q6UB98 | |
| NEPLGLQSQAFKECP | 406 | Q99467 | |
| QDVPEEPNKTCESSN | 681 | Q12830 | |
| PETKCPKQNSIENDI | 1301 | Q12830 | |
| PIPVKQNCFTVNRSL | 61 | Q00975 | |
| DVNDCRPQFSKPQFS | 2501 | Q9H251 | |
| FCTELNQPTLPNIRK | 311 | Q7L9B9 | |
| CKVPLSNENSQVPQS | 411 | Q8IZT6 | |
| KCPVAQLEQDDQVSP | 251 | P32121 | |
| PLTPQQRSFCLQEEK | 531 | O75185 | |
| PEKFSSRIECESPNN | 236 | Q9P241 | |
| ATFCDPETQPNGRQK | 861 | P58397 | |
| KLEDTNCSQVQKPPT | 1451 | P59510 | |
| TKDDCFNVNIQPPVG | 966 | O00203 | |
| LATEKVVQFQASPCP | 331 | Q9UBG7 | |
| VVQFQASPCPKEANR | 336 | Q9UBG7 | |
| PFALKVQTVPQTCDG | 1346 | P20742 | |
| FSQNVCKPVEETQRP | 191 | Q8WWW0 | |
| QPCNEKINVNTITSP | 1141 | Q8TE59 | |
| KGPPVNVTCNIFINS | 66 | O75311 | |
| QIDFSKCAIQNAPNP | 131 | P48200 | |
| QPCSLDPATQKLITN | 181 | Q9Y6F1 | |
| FCLEKLTNIPSDQQP | 591 | Q6TGC4 | |
| PVCNPNKAIFTVDAK | 126 | Q96RG2 | |
| VEDFPVCSPNQASVL | 561 | Q9Y561 | |
| VSLQEKNCEPVVPNA | 86 | Q16655 | |
| DEKTACLIVNNPSNP | 206 | P17735 | |
| DQLKQCFSRQPTEPK | 1511 | Q9BY89 | |
| ILDEEFQNSPPASVC | 411 | Q8TAT5 | |
| PATFCQKNDIELTPP | 486 | Q969R5 | |
| CIRPNNSKLPDTFDN | 1041 | Q9Y6X6 | |
| NNLDKLCGPNVTDFP | 76 | P15018 | |
| QCTPKVDFPQDQLTA | 211 | P40926 | |
| PVSQVNPRDAKACVV | 651 | P05023 | |
| DCQFTSIQKTPNEPQ | 26 | O15327 | |
| PSEVTAIQCKNIPDY | 431 | O60318 | |
| GVAPEQPQNLSCIQK | 121 | Q99665 | |
| CKQPPEAFGFEQATQ | 366 | Q9BY66 | |
| PSKGISVPCQNQEVS | 171 | Q86UF4 | |
| PLTFCDTFPKIDCQQ | 2186 | Q5CZC0 | |
| QNFSFKPCKETQIPL | 461 | P08684 | |
| EQDFSQGPCPTVRQK | 181 | Q6PIU1 | |
| PDCENVKTTQCVFPQ | 281 | P17181 | |
| VTTFGPKACVLQNPQ | 71 | O95544 | |
| CSIEPKFPFSENQIC | 76 | Q8WUM4 | |
| LPDDQIPKTNCNVAV | 401 | Q01813 | |
| QVEANVNKPSLEEPC | 1011 | Q6ZU69 | |
| DSNLEIQCQEFSIPP | 416 | P34910 | |
| IQCQEFSIPPNSDQD | 421 | P34910 | |
| EQCKPVSVTPQGNDF | 936 | Q99550 | |
| KSEPCDDLQIPNTNV | 756 | P48552 | |
| SPQLQVKSSCKENPF | 621 | Q8N3F8 | |
| LQECQDPDTFEPQKF | 16 | P0CE71 | |
| NNLALKDCFVNPQSP | 186 | Q9H3R1 | |
| PNKDEPINCESFKVT | 2136 | P23471 | |
| VNDNKPVFIVPPSNC | 666 | Q9BZA7 | |
| KQICSFLQTAPEQFP | 2556 | Q9Y4D8 | |
| EKVCNFLASQVPFPS | 211 | Q99714 | |
| NYTFICQKKEQEPEP | 226 | Q16821 | |
| ISFQNGTPKNVCQLP | 266 | Q8NB91 | |
| QEVKPNPLQDANLCS | 6 | O15439 | |
| SFQKNPTPCIIPQEQ | 856 | Q13797 | |
| DKATCQETVEPPQTL | 236 | Q8IZD4 | |
| YENANPECQSAIKPL | 481 | P87889 | |
| YENANPECQSAIKPL | 481 | P62683 | |
| YENANPECQSAIKPL | 481 | P63145 | |
| YENANPECQSAIKPL | 481 | Q7LDI9 | |
| YENANPECQSAIKPL | 481 | P63130 | |
| YENANPECQSAIKPL | 481 | P62685 | |
| YENANPECQSAIKPL | 481 | P63126 | |
| YENANPECQSAIKPL | 481 | P62684 | |
| ETCIRAQPENIPAKN | 1201 | P08123 | |
| SNSPIKGADCQEVPQ | 596 | P46100 | |
| VDPNTQNPKYITAAC | 2346 | P42858 | |
| PASKTLQVNCEEIPA | 216 | Q9Y4C1 | |
| GQNPVVTPCNKQFLS | 151 | Q16630 | |
| QNFSFKPCKETQIPL | 461 | Q9HB55 | |
| ERPQSFISPQSCDAQ | 186 | Q9Y6W3 | |
| DVSLNPCNTPQKIFT | 136 | P49454 | |
| NKCTPPNVENGILVS | 236 | P17927 | |
| NKCTPPNVENGILVS | 686 | P17927 | |
| NKCTPPNVENGILVS | 1136 | P17927 | |
| QTVDPTQECFIPQAK | 321 | Q9NZD1 | |
| TQECFIPQAKLSPQQ | 326 | Q9NZD1 | |
| PLVPCNQAKASDVQD | 151 | Q5R3K3 | |
| QLPLPSPQETQKFCE | 76 | O95273 | |
| FIDRKTPNNPSCNAD | 686 | P54289 | |
| CEVFNPISKNQSDPI | 396 | P13688 | |
| NCPVETLKEQSNPAL | 311 | P50613 | |
| KECSNIPLSQPQQGE | 246 | Q9H2C0 | |
| ISPDTTERNNNCPEK | 26 | P12110 | |
| CSQSAPSFKPNQVRD | 381 | Q2V2M9 | |
| ICESDQTKPLSNQPI | 496 | P55287 | |
| KDIPFNLTNNIPGCE | 331 | Q3MJ40 | |
| YPVVKEQSQPCADNA | 326 | P19784 | |
| NKVFTEPQQCFDVAP | 766 | Q6ZMT9 | |
| PNSRFDCAPDKAITQ | 86 | P10253 | |
| NSCQQSPEEGKVEPE | 1411 | Q9P267 | |
| NPEVPVNFAEFSKKC | 31 | O15347 | |
| NFPDTLNCAEVKIFP | 166 | O60259 | |
| PFLAVEVQNQKQPAC | 16 | P07498 | |
| QNFSFKPCKETQIPL | 461 | P24462 | |
| KSQPNLDTCAFHEQP | 96 | P09228 | |
| KSQPNLDTCAFHEQP | 96 | P01037 | |
| TQAQDKRPAVTSQPC | 256 | A6NIJ5 | |
| KDIPFNLTNNIPGCE | 331 | A2RUR9 | |
| PTPLESDQSICAFQN | 596 | P82279 | |
| NEIKPQSVCAPSEQL | 36 | Q05048 | |
| CEVTPDVNISGQKFN | 426 | Q96AC1 | |
| NPQPFLSQAVATKCQ | 121 | Q8WTQ7 | |
| SDTECPEQKQVFANP | 501 | Q86UP8 | |
| SDTECPEQKQVFANP | 501 | Q6EKJ0 | |
| ENQTPEFFQDVCKPK | 1981 | P49327 | |
| ACPTPKEDGLAQQQT | 2201 | P49327 | |
| KSQPNLDTCAFHEQP | 96 | P01036 | |
| FEPNNPVCFLNTDKV | 886 | P51530 | |
| QPCLPSTQEDVINKY | 721 | Q96RP9 | |
| PNDPVTNICQAADKQ | 261 | P19793 | |
| PKVCEIPFNSTNKFQ | 486 | P20648 | |
| EQDPEIVCTIPSKFQ | 381 | Q56UN5 | |
| AQCQEDGPTQNLKPD | 326 | Q9H7T9 | |
| CEVTVQSPTPFNDNQ | 861 | Q96NU0 | |
| SQVLNECTKPDQATP | 611 | Q5VW36 | |
| PDIPNPENCKALQFQ | 871 | P42702 | |
| SCCNQKVPVPSQQLF | 1151 | Q13615 | |
| DLENFLQKAPVPSTC | 146 | Q14980 | |
| FCKQAPEENQPTNES | 146 | Q99487 | |
| PQEDNYPNSLCIKVN | 221 | O75928 | |
| EPKVTTSCPQQGLQA | 36 | Q9BZR6 | |
| QVNCPPAVTENKTVT | 61 | Q16563 | |
| IYNQDSCLQETNPKP | 451 | Q9Y5J1 | |
| VQVCPNYSIPQKTDS | 236 | Q7Z2T5 | |
| PVTQEEVQFKPESLC | 396 | P0C7P3 | |
| LCQPPTKNESEIQFF | 116 | Q8NBJ9 | |
| SSPELNNKCLTPQRE | 1501 | Q9UQ35 | |
| PTLCDPGKQNTDEQF | 831 | Q8IWB6 | |
| NELPNCKINQEDSVP | 561 | Q8TF05 | |
| TQIQPQPGFCIKTNS | 46 | Q9NWS0 | |
| PCVPKLSNSDSQDIQ | 481 | O14545 | |
| SEFFNASCVPVNNPK | 511 | P08582 | |
| RPQDSEFSPVDNCLQ | 781 | Q9ULQ0 | |
| QDSSEQPQEKLCKNP | 1086 | O95425 | |
| KQNEAEPRPQTCSSF | 1821 | O14513 | |
| SANKVPTCEEVIFPN | 581 | P28749 | |
| CPASQNKVQALSLPE | 521 | Q5VVP1 | |
| KLCCVQSPVPSQVVN | 686 | Q8TC59 | |
| SQESPNENFKTVGPC | 1851 | Q5UIP0 | |
| KGPPVNVSCNIFINS | 61 | P23415 | |
| ICCIPNSNLDKAPVQ | 171 | Q569H4 | |
| QCNKRSFSDQPKVTP | 236 | P55055 | |
| GQNPEEPVSVNKCFL | 201 | Q8N165 | |
| VAPFKCSVLPLSQNQ | 611 | P41250 | |
| ASCNSVKVNPAAQPV | 1286 | Q8IVL1 | |
| TGEKPCEQVQFQPNT | 591 | Q9NPR2 | |
| FQCTDPKNCSVELTP | 446 | Q96HU1 | |
| QINCEFEEVVPSSNP | 31 | Q5VXU9 | |
| CNAPAFLFTTQKNTP | 111 | O15466 | |
| FDQPQPEEQCIKTVN | 141 | Q9P031 | |
| KCFLPQNINPDLTLS | 41 | Q8TF17 | |
| LPSVVQKSQEDFCPP | 636 | Q6ZUB0 | |
| VFLGNPDKCPVQQAS | 911 | Q6P1J6 | |
| ANKLQLQEKQTFPPC | 161 | Q8WUJ1 | |
| NEFSQNESKEPDPCL | 61 | Q96P63 | |
| KTQAPFVNLSQPLCN | 616 | Q8N0Z3 | |
| YENANPECQSAIKPL | 481 | P63128 | |
| SPNDPVTNICQAADK | 331 | P28702 | |
| VLASCNPENPEEKFQ | 271 | Q7Z7C7 | |
| PKDQNILPICQDQDF | 571 | Q0P6D6 | |
| CVSKNEDIPNVAVYP | 191 | P54709 | |
| TDYKNPIDQCNTLNP | 36 | O95406 | |
| FNPENNVKESECPLP | 2101 | A4UGR9 | |
| PQPKCADFQSANLFE | 31 | Q53H76 | |
| ICLPEPNFNLKVGTQ | 101 | Q7RTY3 | |
| KIQCLPPSQDEEVQT | 181 | O00584 | |
| SLPNDKEGSCPQVNI | 71 | Q14508 | |
| KEGSCPQVNINFPQL | 76 | Q14508 | |
| PTRYAESQKEPQTCN | 731 | A0JNW5 | |
| LPSVVQKSQEDFCPP | 636 | P0C874 | |
| SIVNKNTPRVNPCDS | 86 | P16415 | |
| KKNPCEVQPDSLTNN | 1031 | Q5W0Q7 | |
| QEAAPEKSSFQCENP | 301 | O15062 | |
| NSPVQPLENQCKTET | 161 | Q86W11 | |
| PNFCPQETEVLVSKV | 126 | Q96NA8 | |
| NQSFEIIKKLECPNP | 1741 | Q8NB66 | |
| VAQPAEKSCLESVQP | 331 | Q9BZQ8 | |
| ATLEPPGCSNKEQQV | 26 | Q9UQP3 | |
| CFRQSQIPPVNDFKV | 51 | Q9UQR0 | |
| CDSVKQPRNIEEPSN | 306 | Q9UNN4 | |
| SVVQKSQEDFCPPAP | 641 | Q6ZQQ2 | |
| TCVLQKCQVTNFPPA | 1276 | Q6ZQQ2 | |
| CPQCNKEFPNQESLL | 666 | Q96K83 | |
| SPQSAPACVENKNDV | 261 | Q6U841 | |
| KPENFSVNCSLPNEN | 1006 | Q9H5I5 | |
| QPQQSTFNPEACFKD | 1436 | O60281 | |
| VPTQVPTKDDDEFCN | 1221 | Q8IZH2 | |
| PKINDATQEPVNCTN | 61 | Q9BX74 | |
| NQQPAAPECKVLTAA | 306 | Q86W42 | |
| PFPTVTSCAVDQENQ | 31 | Q12815 | |
| PEVTQFIKCTSNPAE | 56 | Q96LD8 | |
| EFPKLSQEAQPCSQG | 331 | A6NKC9 | |
| KQASRPPIQNACVAD | 76 | Q96EU6 | |
| CSKNPSTNFQEPVQP | 251 | P19623 | |
| EPKCQPVFSFGNSEQ | 1126 | P49790 | |
| SQERIIQFQATPCPK | 301 | Q06330 | |
| QTPNKPDVTNENVFC | 481 | Q96SK2 | |
| EPLSRKNNVSVQCPE | 256 | Q9Y577 | |
| QCNFDELNTPQSPKD | 446 | Q8NEG5 | |
| EQIENTANPSRCPVK | 1291 | Q9UBW7 | |
| LNQESIQTEEKPYPC | 246 | Q9UJU3 | |
| ETQSECLSPEPQFVQ | 21 | Q8N720 | |
| PQGAPAVEKTFLCQQ | 671 | P59923 | |
| TFTPECENQKDPLVN | 1011 | Q96JM2 | |
| FCKNDVLPLSNSVPE | 66 | Q96EQ0 | |
| FCVPLKDNPNQSLLT | 156 | Q96DR4 | |
| DTGCKFQVLPQPTNL | 171 | Q68D20 | |
| PLEQFVEKSSCAQPL | 41 | Q9UMR3 | |
| QESDSPFVFICKNPQ | 531 | Q15650 | |
| LQSQPKEPQLTCDSA | 166 | O15535 | |
| VQIPQVSSPEFCNQK | 71 | Q9Y6J3 | |
| PDTFTKLINPQENTC | 1706 | Q12789 | |
| PARDGENTQPKQICT | 166 | Q7RTU7 | |
| QLQQQKSVFEICPSP | 321 | Q6N021 | |
| KSVFEICPSPAENNI | 326 | Q6N021 | |
| VTKQENPPASCDNVQ | 1006 | Q6N021 | |
| NPPASCDNVQQKSII | 1011 | Q6N021 | |
| QKVIFSSQAICAPDP | 251 | Q05996 | |
| PNTVVPCGTEKNFTN | 841 | P35125 | |
| KECQTEDTPSQPQII | 966 | Q5VZL5 | |
| VPAAQSSPINCEKRE | 61 | O94782 | |
| VTNTQSLDQQCDPKP | 1351 | Q9BVV6 | |
| SLDQQCDPKPLSRQF | 1356 | Q9BVV6 | |
| CFPEKPVPLSLNQQE | 491 | Q5H9K5 | |
| SFVLHCPDPVQKTNQ | 1081 | Q70EL1 | |
| CDIEKPPTQAAYIAQ | 1526 | Q9P2D8 | |
| CGIKDSPVQSPNFQQ | 1166 | Q9BYP7 | |
| NSCKESEPSQEQFVP | 191 | Q92802 | |
| SPQEAKRPQYCSETQ | 131 | Q86TC9 |